Carlos

PhD. Researcher at the University of Bristol @UoBrisHEB, part of the health economic team at @ARC_West. Interested in implementation science.

[Carlos @csrejon]

Progressively moving to BSKY
https://t.co/IFtBSUNhY0

And Linkdin

[Health Economics & Health Policy @ Bristol @UoBrisHEHP]

Book now for the @ARC_West Improving Resource Use short course. In Bristol 29th April 2025. Led by the
@ARC_West Health Economics team. For more information and to book: https://t.co/SL0q1eGhlK @csrejon @NIHRARCs

[Carlos @csrejon]

@radiogranada Pero yo escucho hora 25, a lo que iba. La próxima vez: mensaje claro y consistente. Y en vez de escudarse en haberlo hecho mal. Disculpas y fin, nada de "peros". Y a ser posible: compensar. Así se arreglan los errores.

[Carlos @csrejon]

@Hora25 @radiogranada Nos habéis dejado fuera, mintiendo, era entrada libre hasta aforo limitado. Han habido entradas. Sin avisarnos nos habéis dejado esperando habiéndonos dicho que entrábamos. Las explicaciones con prepotencia y sin educación.

[Carlos @csrejon]

@AimarBretos

[Carlos @csrejon]

...

[Carlos @csrejon]

Hasta*

[Carlos @csrejon]

.@Hora25 nos habéis dejado fuera horas habiéndonos dicho que entramos. Ha habido enchufes. Así no.

[Carlos @csrejon]

@BrianKingNeo @Dr_KSGautham @KarenLuyt @researchsquare To add...Cost-benefit analysis tends to measure the benefits in consumption equivalent. However, for me, the distinction between cost-effectiveness and cost-benefit analyses is more apparent than real. Neither avoid the question of what an appropriate threshold should be.

[Karen Luyt💙 @KarenLuyt]

Read this #preprint on @researchsquare: Demonstrating the value for money of implementing evidence-based treatment: the case for further investment in magnesium sulphate as a neuroprotectant for preterm births https://t.co/gCX4eadAPc

[The Guardian @guardian]

Why the Guardian is no longer posting on X https://t.co/j4fRgzSYde

[La Vanguardia @LaVanguardia]

📌 'La Vanguardia' deja de publicar tuits de forma directa en la red social X, convertida en una red de desinformación desde la llegada de Musk https://t.co/z2HlbyIIL0

[Karen Luyt💙 @KarenLuyt]

Updated @CochraneLibrary review reaffirms that MgSO4 is effective in reducing cerebral palsy. Implementation into clinical practice needs to be accelerated to translate these benefits into better outcomes for preterm babies worldwide. Link to Review and Editorial👇

[Health Economics & Health Policy @ Bristol @UoBrisHEHP]

❄️HESG Winter 8th-10th Jan 2025 ❄️

We can't wait to welcome you to Bristol!

Submit your abstract by Monday 30th Sept!

[Lane Meredith @Lane_Meredith_]

A day well spent learning and sharing about the integration of #healtheconomics and implementation science and ended with a lovely networking session with some of the delegates #ImplementEcon @warwickmed @WarwickEvidence

[Health Services Research UK @HSRN_UK]

Congratulations to our winner of the #HSRUK24 Best Poster Award Carlos Sillerno Rejon!

His poster ‘Investing in further implementation of MgSO4 for the prevention of cerebral palsy in preterm births would represent a good value for money’ was voted as the best by our delegates!

[Lane Meredith @Lane_Meredith_]

Great poster shared at @HSRN_UK looking forward to working with @csrejon , his team and others next week at the #ImplementEcon workshop

[Carlos @csrejon]

#HSRUK24 @ARC_West @UoBrisHEHP

[Carlos @csrejon]

Come and see this beauty at @HSRN_UK I will be presenting at the poster walkround session 6

[Carlos @csrejon]

Más y más de esto!!

[elDiario.es @eldiarioes]

🔴DIRECTO | Sánchez detalla el precio de las camas UCI, las matrículas educativas y los trasplantes de pulmón: "Díganme qué familia de clase media se podría permitir estos costes si no hubiera un Estado del bienestar fuerte" https://t.co/laTC6KzgVX